VAC-iNTS PROJECT

A Phase I clinical trial assessing the safety and immune response of a GMMA-based vaccine against invasive non-typhoidal Salmonella (iNTS) in healthy adults in Europe and sub-Saharan Africa. It uses advanced immunological and systems biology tools to evaluate antibody responses and support vaccine development. The study aims to lay the groundwork for future large-scale trials and accelerate vaccine availability in regions most affected by iNTS and antibiotic resistance